Cargando…
Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer
SIMPLE SUMMARY: Most breast cancer patients receive chemotherapy as part of their treatment. Unfortunately, treatment outcomes cannot be predicted with the current methods. Therefore, in the preset study, we explore the feasibility of a functional sensitivity test for the chemotherapeutic agents cis...
Autores principales: | Ladan, Marjolijn M., Meijer, Titia G., Verkaik, Nicole S., Komar, Zofia M., van Deurzen, Carolien H. M., den Bakker, Michael A., Kanaar, Roland, van Gent, Dik C., Jager, Agnes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909506/ https://www.ncbi.nlm.nih.gov/pubmed/35267560 http://dx.doi.org/10.3390/cancers14051252 |
Ejemplares similares
-
Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients
por: Ladan, Marjolijn M., et al.
Publicado: (2023) -
Ex vivo tumor culture systems for functional drug testing and therapy response prediction
por: Meijer, Titia G, et al.
Publicado: (2017) -
Tumor slice culture system to assess drug response of primary breast cancer
por: Naipal, Kishan A. T., et al.
Publicado: (2016) -
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests
por: Meijer, Titia G., et al.
Publicado: (2022) -
Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
por: Zhang, Wenhao, et al.
Publicado: (2018)